Matches in SemOpenAlex for { <https://semopenalex.org/work/W147473663> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W147473663 abstract "Abstract Background In the rituximab era, there are several studies that have reported the risk factors for central nervous system (CNS) involvement in non-Hodgkin lymphoma, but the same factors emerge, such as high international prognostic index (IPI) score, >1 extranodal site, elevated lactate dehydrogenase (LDH) level, poor performance status (PS), advanced stage, bone marrow involvement. Macrophages are an important component of the tumor microenvironment and the immune response to malignancy. Recently, elevated peripheral blood monocyte counts have been shown to be an independent marker associated with poor prognosis in patients with both non-Hodgkin and Hodgkin lymphoma. Patients and methods We reviewed data from a total of 1238 lymphoma patients(1185 non-Hodgkin lymphoma, 53 Hodgkin lymphoma) at our institution between February 2005 and May 2013. Of these, 42 patients (3.4%) developed CNS complications during the clinical course. Thirty patients out of these 42 (71.4%) were diagnosed with diffuse large B-cell lymphoma (DLBCL). Therefore, we focused on DLBCL. In this study, we retrospectively analyzed data from a total of 557 DLBCL patients, 30 patients (5.4%) who developed CNS involvement and 527 patients with DLBCL but without CNS involvement. This study was approved by the Institutional Review Board of the Cancer Institute Hospital of the Japanese Foundation for Cancer Research. The clinical features of all 557 DLBCL patients, including 30 patients with CNS involvement, are summarized in Table 1. CNS involvement was defined by the presence of at least one histologically confirmed CNS involvement; neuroimaging findings compatible with CNS involvement with lymphoma, in conjunction with consistent clinical presentation; and the absence of other clinically feasible diagnosis or positive cerebrospinal fluid (CSF) (lymphoma cells detected by cytology). The absolute monocyte counts (AMC) and monocyte ratio were derived from pre-treatment complete blood counts. Pathological studies Immunohistochemical analysis was carried out using mAbs against CD68 at our institution. Results The incidence of CNS involvement was 5.4%, 1.3% having CNS involvement at diagnosis with DLBCL. Intriguingly, absolute monocyte counts (AMC) ≥0.6 (×109/L) at diagnosis were significantly frequent in 30 DLBCL patients (p=0.0420) with CNS involvement, compared with in 527 DLBCL patients without CNS involvement. Furthermore, the monocyte ratio ≥8% in peripheral blood at diagnosis was significantly frequent in 30 DLBCL patients (p=0.0325) with CNS involvement, compared with in 527 DLBCL patients without CNS involvement. DLBCL patients with CNS involvement showed age ≤60 years, stage III-IV, IPI score ≥3, and PS ≥2, elevated soluble IL-2 receptor levels was significantly frequent, compared with in DLBCL patients without CNS involvement. Neither gender, elevated LDH level, white blood cell counts (WBC) differed significantly in the two groups. With regard to pathological immunohistochemistry, the numbers of CD68 positive cells in or around lymphoma samples did not differ in the 14 DLBCL patients with CNS involvement that we were able to analyze, compared with DLBCL patients without CNS involvement. CNS involvement free survival rate in DLBCL patients was significantly lower in AMC ≥0.6 (×109/L) and/or the monocyte ratio ≥8% (Log-rank test, P=0.0102) in peripheral blood at diagnosis, compared with in AMC less than 0.6 (×109/L) and the monocyte ratio less than 8%. Conclusions These results suggest that in DLBCL patients, AMC and monocyte ratios in peripheral blood at diagnosis are closely correlated with the risk of eventual CNS involvement. AMC and monocyte ratios in peripheral blood at diagnosis in DLBCL patients could be a useful prognostic marker for the risk of CNS involvement during the clinical course. Disclosures: Yokoyama: Chugai Pharmaceutical CO., LTD.: Consultancy. Nishimura:Chugai Pharmaceutical CO., LTD.: Consultancy." @default.
- W147473663 created "2016-06-24" @default.
- W147473663 creator A5010120453 @default.
- W147473663 creator A5024418836 @default.
- W147473663 creator A5038191750 @default.
- W147473663 creator A5044544485 @default.
- W147473663 creator A5045462595 @default.
- W147473663 creator A5047640708 @default.
- W147473663 creator A5056066788 @default.
- W147473663 creator A5061465699 @default.
- W147473663 creator A5064541531 @default.
- W147473663 date "2013-11-15" @default.
- W147473663 modified "2023-09-28" @default.
- W147473663 title "Numbers and Percentages Of Peripheral Monocytes Is a Prognostic Marker For CNS Involvement In Diffuse Large B-Cell Lymphoma" @default.
- W147473663 doi "https://doi.org/10.1182/blood.v122.21.1775.1775" @default.
- W147473663 hasPublicationYear "2013" @default.
- W147473663 type Work @default.
- W147473663 sameAs 147473663 @default.
- W147473663 citedByCount "0" @default.
- W147473663 crossrefType "journal-article" @default.
- W147473663 hasAuthorship W147473663A5010120453 @default.
- W147473663 hasAuthorship W147473663A5024418836 @default.
- W147473663 hasAuthorship W147473663A5038191750 @default.
- W147473663 hasAuthorship W147473663A5044544485 @default.
- W147473663 hasAuthorship W147473663A5045462595 @default.
- W147473663 hasAuthorship W147473663A5047640708 @default.
- W147473663 hasAuthorship W147473663A5056066788 @default.
- W147473663 hasAuthorship W147473663A5061465699 @default.
- W147473663 hasAuthorship W147473663A5064541531 @default.
- W147473663 hasConcept C121608353 @default.
- W147473663 hasConcept C126322002 @default.
- W147473663 hasConcept C142724271 @default.
- W147473663 hasConcept C143998085 @default.
- W147473663 hasConcept C2778476033 @default.
- W147473663 hasConcept C2778559949 @default.
- W147473663 hasConcept C2779338263 @default.
- W147473663 hasConcept C2779399171 @default.
- W147473663 hasConcept C2780007613 @default.
- W147473663 hasConcept C2780653079 @default.
- W147473663 hasConcept C2781214270 @default.
- W147473663 hasConcept C71924100 @default.
- W147473663 hasConceptScore W147473663C121608353 @default.
- W147473663 hasConceptScore W147473663C126322002 @default.
- W147473663 hasConceptScore W147473663C142724271 @default.
- W147473663 hasConceptScore W147473663C143998085 @default.
- W147473663 hasConceptScore W147473663C2778476033 @default.
- W147473663 hasConceptScore W147473663C2778559949 @default.
- W147473663 hasConceptScore W147473663C2779338263 @default.
- W147473663 hasConceptScore W147473663C2779399171 @default.
- W147473663 hasConceptScore W147473663C2780007613 @default.
- W147473663 hasConceptScore W147473663C2780653079 @default.
- W147473663 hasConceptScore W147473663C2781214270 @default.
- W147473663 hasConceptScore W147473663C71924100 @default.
- W147473663 hasLocation W1474736631 @default.
- W147473663 hasOpenAccess W147473663 @default.
- W147473663 hasPrimaryLocation W1474736631 @default.
- W147473663 hasRelatedWork W2016413121 @default.
- W147473663 hasRelatedWork W2030841669 @default.
- W147473663 hasRelatedWork W2165570306 @default.
- W147473663 hasRelatedWork W2378215887 @default.
- W147473663 hasRelatedWork W2413868446 @default.
- W147473663 hasRelatedWork W2513688891 @default.
- W147473663 hasRelatedWork W2548617861 @default.
- W147473663 hasRelatedWork W2552704352 @default.
- W147473663 hasRelatedWork W2560844148 @default.
- W147473663 hasRelatedWork W2568245897 @default.
- W147473663 hasRelatedWork W2571242778 @default.
- W147473663 hasRelatedWork W2587685452 @default.
- W147473663 hasRelatedWork W2601731883 @default.
- W147473663 hasRelatedWork W2773013881 @default.
- W147473663 hasRelatedWork W2957092848 @default.
- W147473663 hasRelatedWork W2990087934 @default.
- W147473663 hasRelatedWork W3001151661 @default.
- W147473663 hasRelatedWork W3021234082 @default.
- W147473663 hasRelatedWork W3029896026 @default.
- W147473663 hasRelatedWork W3030957511 @default.
- W147473663 isParatext "false" @default.
- W147473663 isRetracted "false" @default.
- W147473663 magId "147473663" @default.
- W147473663 workType "article" @default.